1 hour ago · Hong Kong
Li Ka-shing funds Asia’s first non-invasive kidney tumour trials in Hong Kong
What's happening
SignalsMonitor is following this as a health story. South China Morning Post Asia is the outlet attached so far. The reports are tied to Hong Kong. The first report grouped here was at 11 Nov 2026, 05:02 UTC. 2 material updates are listed in the timeline. The headline in use is “Li Ka-shing funds Asia’s first non-invasive kidney tumour trials in Hong Kong”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
Hong Kong will become the first city in Asia to conduct clinical trials of a non-invasive treatment for kidney tumours, extending the technology beyond liver and pancreatic cancers, with tycoon Li Ka-shing funding places for 30 patients across three private hospitals. The Li Ka Shing Foundation announced on Wednesday that…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by South China Morning Post Asia
Li Ka-shing funds Asia’s first non-invasive kidney tumour trials in Hong Kong
- New development reported by South China Morning Post Asia
Sound waves, no scalpel: Li Ka-shing extends cancer therapy to kidney tumours
Reported by 1 outlet
- South China Morning Post
- South China Morning PostSound waves, no scalpel: Li Ka-shing extends cancer therapy to kidney tumours